Bank of New York Mellon Portfolio holdings
Bank of New York Mellon (BNY Mellon), tracing its origins to 1784 when Alexander Hamilton founded the Bank of New York, is a global financial institution headquartered in New York City, specializing in asset servicing, custody banking, and investment management. As one of the world’s largest custodian banks, it safeguards trillions in assets for institutions like pension funds, mutual funds, and governments, while its investment arm manages billions through subsidiaries like Mellon Investments and Dreyfus. Known for its role as a financial infrastructure backbone, BNY Mellon also provides treasury services, wealth management, and market analytics, blending a rich historical legacy with modern fintech innovations. The 2007 merger of Bank of New York and Mellon Financial solidified its position as a leader in global finance.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Newell Brands
NWL
|
+$372M |
| 2 |
Edwards Lifesciences
EW
|
+$359M |
| 3 |
Ralph Lauren
RL
|
+$261M |
| 4 |
DXC Technology
DXC
|
+$191M |
| 5 |
Citigroup
C
|
+$181M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$704M |
| 2 |
BCR
CR Bard Inc.
BCR
|
+$696M |
| 3 |
Procter & Gamble
PG
|
+$499M |
| 4 |
Microsoft
MSFT
|
+$493M |
| 5 |
Bank of America
BAC
|
+$453M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 16.92% |
| 2 | Financials | 14.66% |
| 3 | Healthcare | 13.92% |
| 4 | Consumer Discretionary | 9.78% |
| 5 | Industrials | 9.65% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
ICPT
2051
DELISTED
Intercept Pharmaceuticals, Inc.
ICPT
| $8.66M | ﹤0.01% |
71,549
+3,247
| +5% | +$376K |
|
|
LDR
2052
DELISTED
Landauer Inc
LDR
| $8.66M | ﹤0.01% |
165,535
-2,051
| -1% | -$106K |
|
2053
American Vanguard Corp
AVD
$62.5M
| $8.64M | ﹤0.01% |
500,892
+46,114
| +10% | +$794K |
|
|
HRG
2054
DELISTED
HRG Group, Inc.
HRG
| $8.64M | ﹤0.01% |
487,703
+509
| +0.1% | +$9.56K |
|
|
DPLO
2055
DELISTED
DIPLOMAT PHARMACY, INC.
DPLO
| $8.64M | ﹤0.01% |
583,597
+10,806
| +2% | +$180K |
|
|
LBAI
2056
DELISTED
Lakeland Bancorp Inc
LBAI
| $8.63M | ﹤0.01% |
457,918
+43,563
| +11% | +$840K |
|
|
AIMC
2057
DELISTED
Altra Industrial Motion Corp
AIMC
| $8.63M | ﹤0.01% |
216,876
+23,094
| +12% | +$947K |
|
2058
National Presto Industries
NPK
$1B
| $8.6M | ﹤0.01% |
77,843
+3,764
| +5% | +$397K |
|
|
VG
2059
DELISTED
Vonage Holdings Corporation
VG
| $8.6M | ﹤0.01% |
1,314,316
-104,441
| -7% | -$698K |
|
2060
Team
TISI
$101M
| $8.59M | ﹤0.01% |
36,607
+929
| +3% | +$239K |
|
2061
Amphastar Pharmaceuticals
AMPH
$889M
| $8.55M | ﹤0.01% |
478,646
-41,156
| -8% | -$653K |
|
2062
Forestar Group
FOR
$1.5B
| $8.54M | ﹤0.01% |
498,316
+6,445
| +1% | +$96.1K |
|
2063
Stride
LRN
$3.46B
| $8.52M | ﹤0.01% |
475,484
+2,100
| +0.4% | +$40.3K |
|
2064
MPLX
MPLX
$60.3B
| $8.49M | ﹤0.01% |
254,276
+83,229
| +49% | +$2.88M |
|
2065
NeoGenomics
NEO
$2.05B
| $8.46M | ﹤0.01% |
943,784
+160,773
| +21% | +$1.28M |
|
2066
Travere Therapeutics
TVTX
$5.86B
| $8.43M | ﹤0.01% |
434,699
+46,967
| +12% | +$852K |
|
|
JUNO
2067
DELISTED
Juno Therapeutics, Inc.
JUNO
| $8.43M | ﹤0.01% |
281,858
+19,057
| +7% | +$470K |
|
|
MSFG
2068
DELISTED
MainSource Financial Group Inc
MSFG
| $8.43M | ﹤0.01% |
251,428
+19,462
| +8% | +$645K |
|
|
MYCC
2069
DELISTED
ClubCorp Holdings, Inc.
MYCC
| $8.4M | ﹤0.01% |
641,001
-44,740
| -7% | -$608K |
|
|
SNCR
2070
DELISTED
Synchronoss Technologies
SNCR
| $8.36M | ﹤0.01% |
56,480
-9,806
| -15% | -$1.46M |
|
2071
Unitil
UTL
$995M
| $8.36M | ﹤0.01% |
173,035
-2,411
| -1% | -$115K |
|
|
LL
2072
DELISTED
LL Flooring Holdings, Inc.
LL
| $8.35M | ﹤0.01% |
333,229
+27,238
| +9% | +$684K |
|
|
WEB
2073
DELISTED
Web.com Group, Inc.
WEB
| $8.28M | ﹤0.01% |
327,469
+63,061
| +24% | +$1.33M |
|
2074
Theravance Biopharma
TBPH
$881M
| $8.27M | ﹤0.01% |
207,707
+1,684
| +0.8% | +$64.7K |
|
2075
Myers Industries
MYE
$1.24B
| $8.24M | ﹤0.01% |
459,293
-3,529
| -0.8% | -$60.6K |
|
Similar funds
Bank of New York Mellon's Q2 2017 Portfolio in Review
As of Q2 2017, Bank of New York Mellon held 4,483 positions worth $355B, down 1.8% from $361B the previous quarter. Its ten largest holdings account for 13% of the portfolio.
Bank of New York Mellon withdrew a net $14.1B in Q2 2017, closing 191 positions and reducing 1,987 holdings. Its most notable exit was Yahoo Inc, an estimated $341M position sold in full.
By sector, the portfolio is most concentrated in Technology at 17% of assets, up from 17% a quarter earlier, followed by Financials and Healthcare.
Against the trend, Bank of New York Mellon opened a new position in DXC Technology worth $191M.
- Bank of New York Mellon's largest Q2 2017 buy was DXC Technology: 2,883,543 shares worth $191M.
- Bank of New York Mellon added most to Newell Brands in Q2 2017, an estimated $372M increase.
- Bank of New York Mellon's biggest Q2 2017 reduction was Apple, cutting an estimated $704M.
- Bank of New York Mellon fully exited Yahoo Inc in Q2 2017, selling an estimated $341M.
- Bank of New York Mellon's ten largest holdings make up 13% of its $355B portfolio in Q2 2017.
- Bank of New York Mellon opened 200 new positions and closed 191 in Q2 2017.
- Bank of New York Mellon's portfolio value fell 1.8% quarter-over-quarter to $355B.
Based on Bank of New York Mellon's 13F filing for Q2 2017, filed 3 Aug 2017.